Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
38.26
+0.73 (1.95%)
At close: Oct 7, 2026, 4:00 PM EDT
37.60
-0.66 (-1.73%)
Pre-market: Oct 8, 2026, 6:36 AM EDT

Novo Nordisk Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of $46.07. The average 1-year stock price forecast is 20.41% higher than the current stock price, while the lowest is $39.76 (+3.92%) and the highest is $61.81 (+61.55%).

Price Target: $46.07 (+20.41%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$39.76$46.07$44.62$61.81
Change+3.92%+20.41%+16.62%+61.55%

Analyst Ratings

The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy444333
Buy100000
Hold91010111010
Sell000000
Strong Sell000011
Total141414141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BMO Capital
BMO Capital
Hold
Maintains
$47
HoldMaintains$47+22.84%Oct 7, 2026
TD Cowen
TD Cowen
Hold
Maintains
$42
HoldMaintains$42+9.78%Sep 23, 2026
Unknown Analyst
Jefferies
No rating
Jefferies
Hold
Maintains
$42
HoldMaintains$42+10.30%Sep 22, 2026
Morgan Stanley
Morgan Stanley
Sell
Downgrades
$40
SellDowngrades$40+4.55%Sep 11, 2026
Berenberg Bank
Berenberg Bank
Hold
Downgrades
$50 → $47
HoldDowngrades$50 → $47+22.84%Aug 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
300.49B
from 309.06B
Decreased by -2.77%
Revenue Next Year
304.51B
from 300.49B
Increased by 1.34%
EPS This Year
21.55
from 23.03
Decreased by -6.42%
EPS Next Year
21.92
from 21.55
Increased by 1.70%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
140.80B176.95B232.26B290.40B309.06B300.49B
Revenue Growth
10.91%25.68%31.26%25.03%6.43%-2.77%
Gross Profit
117.14B148.53B196.94B246.84B254.69B239.87B
Gross Margin
83.20%83.94%84.79%85.00%82.41%79.83%
Operating Income
59.22B75.62B104.70B138.90B140.62B123.11B
Net Income
47.76B55.53B83.68B100.99B102.43B98.69B
EPS
----23.0321.55
EPS Growth
----1.77%-6.42%
Forward PE
-----11.87
Dividend / Share
5.206.209.4011.4011.7011.40
Dividend Growth
14.29%19.23%51.61%21.28%2.63%-2.56%
Free Cash Flow
----58.96B57.89B
No. Analysts
-----27
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.

Revenue Forecast

Revenue202620272028
High333.9B
Avg300.5B
Low272.7B

Revenue Growth

Revenue Growth202620272028
High
8.0%
Avg
-2.8%
Low
-11.8%

EPS Forecast

EPS202620272028
High23.59
Avg21.55
Low18.59

EPS Growth

EPS Growth202620272028
High
2.4%
Avg
-6.4%
Low
-19.3%